Table of Contents:
  • v.1. Production and purification
  • Concepts in development of manufactoring strategies for monoclonal antibodies
  • Antibody fragments : production , purification and formatting for therapeutic applications
  • Large scale production of therapeutic antibodies : considerations for optimizing product capture and purification
  • Scale-up of antibody purification from laboratory scale to production
  • Purification of antibody by chromatographic methods
  • Quality control of antibodies for human use
  • Expression of human anti Rh(D) monoclonal antibodies into different cell lines : influence on their functional properties
  • Monoclonal antibody production : minimising virus safety issues
  • Contract manufactoring of biopharmaceutical grade antibodies
  • The pharmacokinetics and pharmacodynamics of monoclonal antibodies
  • Regulatory and legal requirements for the manufacture of antibodies
  • v.2. Novel technologies and therapeutic use
  • Transgenic technology for monoclonal antibody production
  • Generation, engineering and production of human antibodies using HuCAL
  • Achieving appropriate glycodylation during the scaleup of antibody production
  • Approaches to devise antibody purification processes by chromatography
  • Novel HIV neutralizing antibodies selected from phage display libraries
  • Monoclonal and bispecific antibodies in combination with radiotherapy for cancer treatment
  • Antibodies, a potent tool to target genes into designated cells and tissues
  • Intrabodies : development and application in functional genomics and therapy
  • Expression of recombinant antibodies by tumour cells : on road to anti-tumour therapy
  • Antitumor antibodies : from research to clinic
  • Macrophages for immunotherapy
  • Future prospects in antibody engineering and therapy